Research

Alzheimer Europe has been involved in a number of European projects. In particular, we recently carried out a five-country survey on the "Value of Knowing" and the general public's perceptions, experience and knowledge of Alzheimer's disease. We also coordinated the European Collaboration on Dementia (EuroCoDe), are involved in the ambitious PharmaCog project (“Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development”) and carried out a number of European comparative studies, helping to identify the similarities but also the vast differences which exist in the different countries’ approaches to dementia.

Clinical Trials Watch

The Clinical Trial Watch provides current and dementia-friendly information on phase II and III clinical trials that are investigating drugs for Alzheimer’s disease and/or dementia in Europe.

Value of Knowing

A five country survey of Alzheimer Europe examined public perceptions and awareness of Alzheimer’s disease and aimed to identify the views of the general public on the value of diagnosis. Find out more about the results from France, Germany, Poland, Spain and the US.

European Collaboration on Dementia

The Commission financed EuroCoDe project brought together experts from across Europe to look into the prevalence, prevention, socio-economic cost, psychosocial interventions, diagnosis and treatment in dementia and the social support of people with dementia and their carers.

PharmaCog

Find out more about PharmaCog, the most ambitious European project for tackling bottlenecks in Alzheimer's disease research and drug discovery.

Understanding dementia research

Alzheimer Europe provides, in our Dementia Reseach Observatory, information on the benefits, risks and and drawbacks of participating in research as well as the different type of research and clincial trials which exist.